glp-1 stroke risk Stroke: GLP-1s Like Ozempic, Mounjaro May Reduce Cardiovascular Risks Efficacy of glucagon-like peptide-1 receptor

"There are basically no published human efficacy trials for BPC-157." Phillips says all he can find is one small safety study from a decade ago, and a trial that only started enrolling participants this past February

ArticlePubMed 4

Safety, Regulation, and Legal Status of BPC57 BPC157 has been shown to have neurological effects, such as reducing the symptoms of alcohol withdrawal in mice and altering the response to alcohol, and it can also affect the gut-brain axis, leading to changes in dopaminergic signaling and potentially interacting with medications like Adderall, 5m10s

While effective for reducing blood clots, these medications can all cause serious bleeding side effects

Glutathione: Physiological and clinical relevance